Atomos has announced its FY26 full-year results. According to its CEO, the company continues to make real progress in rebuilding and strengthening the business.
For FY26, revenue grew 22.5% to $40.0 million, while fixed costs reduced by 22.5%. EBITDA improved by $15.5 million, moving from a loss of $11.8 million last year to positive EBITDA of $3.7 million this year.
During the year, Atomos completely refreshed its product range, launched six new products and welcomed Flanders Scientific into the Atomos Group.
Overview of operating results
Revenue for FY26 was $40.0m, an increase of 22.5% on the previous corresponding period. Contribution margin improved to $14.9m, or 37.2% of revenue, from $5.5m, or 16.8% of revenue, reflecting improved product cost outcomes. Total fixed costs reduced by 22.5% to $12.5m, with employee benefits expense down $1.8m, advertising and marketing expense down $1.4m, and legal and professional services down $1.0m following the
restructuring completed in the prior year.
The Group recorded EBITDA of $3.7m in FY26 compared with an EBITDA loss of $11.9m in FY25, and a net profit after tax of $0.9m in FY26 compared with a net loss of $14.6m in FY25. Finance costs increased to $2.6m from $1.4m, reflecting the higher average level of borrowings during the year. The income tax benefit of $0.6m principally reflects the recognition of a deferred tax asset against the deferred tax liability arising on the intangible assets recognised in the Flanders Scientific business combination.
The reported result includes a number of individually significant items, being a net benefit of $1.4m arising on inventory which had previously been written down and the release of $0.5m of onerous contract and
open purchase order provisions no longer required. Together these represent a net benefit of $1.9m, against a net charge of $1.5m in respect of the same categories in the previous corresponding period.
The result comprises a first half revenue $23.7m and EBITDA $1.9m, and a second half of revenue $16.3m and EBITDA $1.8m. The Company updated the market on second-half trading on 6 July 2026.
Dividends
No dividends have been paid or declared during the period, and it is not proposed that any dividend be paid. No dividends were paid during the previous corresponding period. As no dividend is proposed, no record date arises, and there is no amount per security or franked amount per security to report.
Returns to shareholders, including distributions and buy-backs
There were no returns to shareholders, including distributions or buy-backs, during the period or the previous corresponding period.
